By Dr William Brooks

Journal articles

Munch G; Shepherd CE; Mccann H; Brooks WS; Kwok JB; Arendt T; Hallupp M; Schofield PR; Martins RN; Halliday GM, 2002, 'Intraneuronal advanced glycation endproducts in presenilin-l Alzheimer's disease', Neuroreport, 13, pp. 601 - 604

Mann DMA; Pickering-Brown SM; Takeuchi A; Iwatsubo T; Arango J; Bird T; Van Broeckhoven C; Brooks W; Brown R; Cairns N; Cras P; Ellison D; Haltia M; Ii K; Jorgensen A; Krill J; Lantos P; Lippa C; Martins R; Nochlin D; Pollen D; Rosenberg C; Rossor M; Tabira T, 2001, 'Amyloid angiopathy and variability in amyloid β deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease', American Journal of Pathology, 158, pp. 2165 - 2175, http://dx.doi.org/10.1016/S0002-9440(10)64688-3

Piguet O; Grayson DA; Ridley L; Bennett HP; Lye TC; Brooks WS; Creasey H; Broe GA, 2001, 'Executive functions in very old individuals and MRI white matter lesions: Do they matter? Evidence from the Sydney Older Persons Study', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 53, pp. 198 - 198, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000202876001407&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Waite LM; Creasey H; Grayson DA; Edelbrock D; Cullen J; Brooks WS; Casey B; Bennett HP; Broe T, 2001, 'Clinical diagnosis and disability among community dwellers aged 75 and over: The Sydney older persons study.', Australasian Journal on Ageing, 20, pp. 67 - 72

Stanford PM; Halliday GM; Brooks WS; Kwok JB; Schofield PR, 2001, 'Progressive supranuclear palsy, frontotemporal dementia with parkinsonism linked to chromosome 17 and familial tauopathies.', Brain, 124, pp. 1668 - 1670

Kwok JB; Mclean C; Kril J; Broe T; Nicholson GA; Cappai R; Hallupp M; Cotton R; Schofield PR; Brooks WS; Smith MJ, 2001, 'Variable phenotypes of Alzheimer`s disease with spastic paraparesis', Annals of Neurology, pp. 125 - 129

Milward E; Grayson D; Creasey H; Kyngdon B; Janu M; Brooks W; Broe GA, 2000, 'Clinical issues - Anaemia and dementia in community-dwelling Australian elderly', AUSTRALASIAN JOURNAL ON AGEING, 19, pp. 25 - 25, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000086449500094&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Broe T; Grayson DA; Creasey H; Waite LM; Casey B; Bennett HP; Brooks WS; Halliday GM, 2000, 'Anti-inflammatory drugs protect against Alzheimer's disease at low doses', Archives of Neurology, pp. 1586 - 1591

Stanford PM; Halliday GM; Brooks WS; Kwok JB; Storey CE; Creasey H; Morris J; Fulham MJ; Schofield PR, 2000, 'Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene. Expansion of the disease phenotype caused by tau gene mutations', Brain, 123, pp. 880 - 893

Stanford PM; Halliday GM; Brooks WS; Kwok JB; Storey CE; Creasey H; Morris JG; Fulham MJ, 2000, 'Tau gene mutations are pleiotropic: Identification of two novel mutations in the tau gene', Neurobiology of Aging, 21, pp. 36 - 36, http://dx.doi.org/10.1016/s0197-4580(00)82837-7

Kwok JBJ; Smith MJ; Brooks WS; Kril J; Mclean C; Hallupp M; Schofield PR, 2000, 'Variable presentation of Alzheimer's disease and/or spastic paraparesis phenotypes in pedigrees with a novel PS-1 exon 9 gene deletion or exon 9 splice acceptor mutations', Neurobiology of Aging, 21, pp. 25 - 25, http://dx.doi.org/10.1016/s0197-4580(00)82789-x

Milward EA; Grayson DA; Creasey H; Janu MR; Brooks WS; Broe GA, 1999, 'Evidence for association of anaemia with vascular dementia', NeuroReport, 10, pp. 2377 - 2381, http://dx.doi.org/10.1097/00001756-199908020-00029

Laws SM; Taddei K; Martins G; Paton A; Fisher C; Clarnette R; Hallmayer J; Brooks WS; Gandy SE; Martins RN, 1999, 'The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease', NeuroReport, 10, pp. 879 - 882, http://dx.doi.org/10.1097/00001756-199903170-00038

Laws SM; Taddei K; Fisher C; Small D; Clarnette R; Hallmayer J; Brooks WS; Kwok JB; Schofield PR; Gandy SE; Martins RN, 1999, 'Evidence that the butyrylcholinesterase K variant can protect against late-onset Alzheimer`s disease', Alzheimers Reports, 2, pp. 219 - 223

Mcritchie DA; Reid WG; Halliday GM; Hely MA; Brooks WS; Morris J, 1999, 'Neuropathology of three clinical cases prospectively diagnosed with diffuse Lewy body disease', Journal of Clinical Neuroscience, pp. 149 - 154

Taddei K; Yang D; Fisher C; Clarnette R; Hallmayer J; Barnetson R; Maller R; Brooks WS; Whyte S; Nicholson GA; Masters CL; Broe GA; Gandy SE; Martins RN, 1998, 'No association of presenilin-1 intronic polymorphism and Alzheimer's disease in Australia', Neuroscience Letters, 246, pp. 178 - 180, http://dx.doi.org/10.1016/S0304-3940(98)00248-1

Taddei K; Kwok JB; Kril J; Halliday GM; Creasey H; Hallupp M; Fisher C; Brooks WS; Chung C; Andrews C; Masters C; Schofield PR; Martins RN, 1998, 'Two novel presenilin-1 mutations (Ser169Leu and Pro436Gln) associated with very early onset Alzheimer's disease.', Neuroreport, pp. 3335 - 3339

Cullen KM; Halliday GM; Double KL; Brooks WS; Creasey H; Broe GA, 1997, 'Cell loss in the nucleus basalis is related to regional cortical atrophy in Alzheimer's disease', Neuroscience, 78, pp. 641 - 652, http://dx.doi.org/10.1016/S0306-4522(96)00569-6

Halliday GM; Brooks WS; Arthur HA; Creasey H; Broe T, 1997, 'Further evidence for an association between a mutation in the APP gene and Lewy body formation', Neuroscience Letters, pp. 49 - 52

Cullen K; Halliday GM; Double KL; Brooks WS; Creasey H; Broe T, 1997, 'Nucleus basalis cell loss is related to regional volumetric brain changes in Alzheimer's disease', Neuroscience, pp. 641 - 652

Kwok JB; Taddei K; Hallupp M; Fisher C; Brooks WS; Broe T; Hardy J; Fulham MJ; Nicholson GA; Stell R; St George-Hyslop PH; Fraser PE; Kakulas B; Clarnette R; Relkin N; Gandy SE; Schofield PR; Martins RN, 1997, 'Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer`s disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype', Neuroreport, pp. 1537 - 1542

Yang JG; Poropat RA; Brooks WS; Broe GA; Nicholson GA, 1996, 'Apolipoprotein E genotyping in Alzheimer's disease in an Australian sample', Australian and New Zealand Journal of Medicine, 26, pp. 658 - 661, http://dx.doi.org/10.1111/j.1445-5994.1996.tb02936.x

Hely MA; Reid WG; Halliday GM; Mcritchie DA; Leicester J; Joffe R; Brooks WS; Broe T; Morris J, 1996, 'Diffuse Lewy body disease: Clinical features in nine cases without co-existent Alzheimer's disease', Journal of Neurology Neurosurgery and Psychiatry, pp. 532 - 538

Harasty JA; Halliday GM; Code C; Brooks WS, 1996, 'Quantification of cortical atrophy in a case of progressive fluent asphsia', Brain, 119, pp. 181 - 190

Double KL; Halliday GM; Kril J; Harasty JA; Cullen K; Brooks WS; Creasey H; Broe T, 1996, 'Topography of brain atrophy during normal aging and Alzheimer's disease', Neurobiology of Aging, 17, pp. 513 - 521

Brooks WS; Martins RN; De Voecht J; Nicholson GA; Schofield PR; Kwok JBJ; Fisher C; Yeung LU; Van Broeckhoven C, 1995, 'A mutation in codon 717 of the amyloid precursor protein gene in an Australian family with Alzheimer's disease', Neuroscience Letters, 199, pp. 183 - 186, http://dx.doi.org/10.1016/0304-3940(95)12046-7

Martins RN; Clarnette R; Fisher C; Broe GA; Brooks WS; Montgomery P; Gandy SE, 1995, 'ApoE genotypes in australia: Roles in early and late onset alzheimer’s disease and down’s syndrome', NeuroReport, 6, pp. 1513 - 1516, http://dx.doi.org/10.1097/00001756-199507310-00012

Maltby N; Broe GA; Creasey H; Jorm AF; Christensen H; Brooks WS, 1994, 'Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: Double blind trial', BMJ, 308, pp. 879, http://dx.doi.org/10.1136/bmj.308.6933.879

Martins RN; Muir J; Brooks WS; Creasey H; Montgomery P; Sellers P; Broe GA, 1993, 'Plasma amyloid precursor protein is decreased in alzheimer’s disease', NeuroReport, 4, pp. 757 - 759, http://dx.doi.org/10.1097/00001756-199306000-00040

Halliday GM; McCann HL; Pamphlett R; Brooks WS; Creasey H; McCusker E; Cotton RGH; Broe GA; Harper CG, 1992, 'Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation', Acta Neuropathologica, 84, pp. 638 - 650, http://dx.doi.org/10.1007/BF00227741

Conference Papers

Dobson-Stone C; Luty A; Thompson E; Blumbergs P; Brooks W; Shepherd C; Yerbury J; Halliday G; Schofield P; Kwok J, 2016, 'Identification Of A novel FTD-MND gene on chromosome 16', in JOURNAL OF NEUROCHEMISTRY, WILEY-BLACKWELL, GERMANY, Munich, pp. 230 - 230, presented at 10th International Conference on Frontotemporal Dementias, GERMANY, Munich, 31 August 2016 - 02 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000382568400030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dobson-Stone C; Luty AA; Thompson EM; Blumbergs P; Brooks WS; Halliday GM; Schofield PR; Kwok JBJ, 2012, 'Identification Of A Locus For Frontotemporal Dementia - Motor Neuron Disease On Chromosome 16p12.1-q12.2', in DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, KARGER, ENGLAND, Manchester, pp. 82 - 82, presented at 8th International Conference on Frontotemporal Dementias, ENGLAND, Manchester, 05 September 2012 - 07 September 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308612400120&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Schofield PR; Luty A; Kwok JB; Thompson E; Blumbergs P; Brooks WS; Loy CT; Dobson-Stone C; Panegyres P; Hecker J; Nicholson GA; Halliday GM, 2008, 'Linkage to chromosome 9 and examination of candidate genes in a pedigree with FTLD-MND and TDP-43 positive neuropathology', in Dementia and Geriatric Cognitive Disorders, Karger, Basel, Switzerland, pp. 9 - 9, presented at 6th International Conference on Frontotemporal Dementias, Rotterdam, Netherlands, 03 September 2008 - 05 September 2008

Song YC; Halliday GM; Creasey H; Morris JG; Brooks WS; Kril J, 2005, 'Neuropathology in the S305S tau gene mutation', in Journal of the Neurological Sciences, Elsevier Science BV, Amsterdam, Netherlands, pp. S302 - S302, presented at XVIIIth World Congress of Neurology, Sydney, 05 November 2005 - 11 November 2005

Huang Y; Hayes M; Harding AJ; Brooks WS; Fung VS; Rowe DB; Hely MA; Halliday GM, 2005, 'Genetic anticipation in familial Lewy body disease', in Parkinsonism and Related Disorders, Elsevier Sci Ltd, Kidlington, Oxford, England, pp. 254 - 254, presented at 16th International Congress on Parkinson`s Disease and Related Disorders, Berlin, Germany, 05 June 2005 - 09 June 2005

Brooks WS; Kwok JB; Halliday GM; Godbolt AK; Rossor MN; Creasey H; Jones A; Schofield PR, 2004, 'Familial Alzheimer's disease and cerebral haemorrhage: A second family with the Flemish APP ALA692GLY mutation', in Neurobiology of Aging, Elsevier Science Inc, New York, NY, USA, pp. S499 - S499, presented at 9th International Conference on Alzheimer's Disease and Related Disorders, Philadelphia, Pennsylvania, 17 July 2004 - 22 July 2004

Brooks WS; Stanford PM; Teber ET; Hallupp M; Mclean C; Halliday GM; Martins RN; Kwok JB; Schofield PR, 2004, 'Screening for tau mutations: an Australian series', in Internal Medicine Journal, Blackwell Publishing Asia, Carlton, VIC, pp. A59 - A59, presented at Annual Scientific Meeting of the Australian Society for Geriatric Medicine, Fremantle, WA, 27 April 2004 - 30 April 2004

Gregory GC; Kwok JB; Shepherd CE; Brooks WS; Xuereb J; Schofield PR; Halliday GM, 2004, 'Beta-amyloid toxicity in Alzheimer's disease', in Proceedings of Aust Neuroscience Society, Melbourne Convention Centre, pp. 42 - 42, presented at 24th Annual Meeting of the Australian Neuroscience Society, Melbourne Convention Centre, 27 January 2004 - 30 January 2004

Shepherd CE; Stanford PM; Brooks WS; Kwok JB; Schofield PR; Brodaty H; Martins RN; Halliday GM, 2003, 'Absence of tau pathology in a familial frontotemporal dementia case with a mutation in the tau gene', in Proceedings of Aust Neuroscience Society, Adelaide, Sth Aust, pp. 375 - 375, presented at 23rd Annual Meeting of the Australian Neuroscience Society, Adelaide, Sth Aust, 28 January 2003 - 31 January 2003

Gregory GC; Kril J; Macdonald V; Png F; Patel S; Brooks WS; Schofield PR; Halliday GM, 2003, 'Familial Alzheimer's disease differs from sporadic in the severity of degeneration', in Proceedings of Aust Neuroscience Society, Adelaide, Sth Aust, pp. 376 - 376, presented at 23rd Annual Meeting of the Australian Neuroscience Society, Adelaide, Sth Aust, 28 January 2003 - 31 January 2003

Harding AJ; Das A; Kril J; Brooks WS; Halliday GM, 2002, 'The frequency of familial lewy body diseases', in Proceedings of Aust Neuroscience Society, Darling Harbour, Sydney, pp. 134 - 134, presented at 22nd Annual meeting of the Australian Neuroscience Society, Darling Harbour, Sydney, 04 February 2002 - 06 February 2002

Harding AJ; Das A; Kril J; Brooks WS; Halliday GM, 2002, 'Frequency of familial Lewy body diseases', in Australian New Zealand Society of Neuropathology Annual General Meeting, presented at Australian New Zealand Society of Neuropathology Annual General Meeting

Broe T; Corbett AD; Bennett HP; Brooks WS; Kril J; Halliday GM; Grayson DA, 1998, 'White matter lesions, cognitive decline and dementia: A 6 year follow-up', in Neurobiology of Aging, Elsevier Science Inc, New York, NY, USA, pp. S243, presented at 6th International Conference on Alzheimer`s Disease and Related Disorders, Amsterdam, Netherlands, 18 July 1998 - 23 July 1998

Aguzzi A; Barbara J; Brown P; Budka H; Diringer H; Dormont D; Flanagan P; Heeschen W; Hope J; Hornlimann B; Kenney K; Masters C; Macnaughton MR; Pocchiari M; Rohwer RG; Safar J; Somogyi A; Tateishi J; Taylor D; Van Duijn CM; Wilesmith JW; Will R; Wisher M; Asher D; De Pedro J; Feek C; Hasebe K; Horaud F; Lower J; Minor P; Nandapalan P; Pavlov A; Perez AC; Ricketts M; Vicari G; Van Aken WG; Beal R; Menache-Aronson D; Bradley R; Bailey A; Chalumeau HP; Garland A; Brooks W; Schrieber R; Sprengers E; Andjaparidze AG; Bolis CL; Emmanuel JC; Griffiths E; Heymann DL; Kaboyo W; Meslin FX; Miyagawa S; Marroquin AP; Schudel A; Zeidler M, 1997, 'Medicinal and other products and human and animal transmissible spongiform encephalopathies: Memorandum from a WHO meeting', in Bulletin of the World Health Organization, pp. 505 - 513

Halliday GM; Brooks WS; Arthur HA; Creasey H; Broe T, 1997, 'Familial Alzheimer's disease, chromosome 21 and Parkinson's disease', in Brain Pathology, Int Society Neuropathology, Los Angeles, CA, USA, pp. 1369 - 1369, presented at XIIIth International Congress of Neuropathology, Perth, WA, 07 September 1997 - 12 September 1997

Halliday GM; Mccann H; Brooks WS; Broe T, 1997, 'Inflammation in Alzheimer's disease: anti-inflammatory medications increase post-mortem neuropathology', in Brain Pathology, Int Society Neuropathology, Los Angeles, CA, USA, pp. 1054 - 1054, presented at XIIIth International Congress of Neuropathology, Perth, WA, 07 September 1997 - 12 September 1997

Halliday GM; Mccann H; Brooks WS; Broe T, 1997, 'Inflammation in Alzheimer's disease: anti-inflammatory medications increase post-mortem neuropathology', in Andrews GR; Mykyta LJ; Andrews MM; Pearson SA; Gregory AJ; Hagger JC (eds.), 16th Congress of the International Association of Gerontology, Adelaide, Sth Aust, pp. 398 - 398, presented at 16th Congress of the International Association of Gerontology, Adelaide, Sth Aust, 19 August 1997 - 23 August 1997

Halliday GM; Brooks WS; Arthur HA; Nicholson GA; Yeung LM, 1997, 'Familial Alzheimer's disease, chromosome 21 and Parkinson's disease', in Journal of Clinical Neuroscience, Churchill Livingstone, Edinburgh, Midlothian, Scotland, pp. 386 - 387, presented at Australian Association of Neurologists Annual Scientific Meeting 1997, Sydney, 30 April 1997 - 02 May 1997

Conference Posters

Song YE; Halliday GM; Creasey H; Morris J; Brooks WS; Kril J, 2005, 'Neuropathology in the S305S Tau gene mutation', Vol. 238, pp. S302 - S302

Conference Abstracts

Bateman R; Aschenbrenner A; Benzinger T; Clifford D; Cruchaga C; Fagan A; Farlow M; Goate A; Gordon B; Hassenstab J; Jack C; Koeppe R; McDade E; Mills S; Morris JC; Salloway S; Santacruz A; Snyder P; Wang G; Xiong C; Snider BJ; Mummery C; Surti G; Didier H; Wallon D; Berman S; Lah J; Jimenez-Velazquez IZ; Roberson E; Van Dyck C; Honig LS; Valle RS; Brooks WS; Gauthier S; Masters C; Galasko D; Brosch J; Hsiung R; Jayadev S; Formaglio M; Masellis M; Clarnette R; Pariente J; Dubois B; Pasquier F; Andersen S; Holdridge K; Mintun M; Sims J; Yaari R; Baudler M; Delmar P; Doody R; Fountouro P; Kerchner G, 2020, 'DIAN-TU Alzheimer's Disease Prevention Trial of Solanezumab and Gantenerumab: Amyloid, Tau and Neurodegeneration Outcomes', in ANNALS OF NEUROLOGY, WILEY, ELECTR NETWORK, Vol. 88, pp. S103 - S103, presented at 145th Annual Meeting American-Neurological-Association, ELECTR NETWORK, 04 October 2020 - 09 October 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000572509100139&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page